These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27428284)

  • 21. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
    Salah Z; Itzhaki E; Aqeilan RI
    Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism.
    Zhao L; Guan H; Song C; Wang Y; Liu C; Cai C; Zhu H; Liu H; Zhao L; Xiao J
    Bone; 2018 May; 110():177-186. PubMed ID: 29432919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
    Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
    Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.
    Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH
    Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.
    Li L; Liu T; Li Y; Wu C; Luo K; Yin Y; Chen Y; Nowsheen S; Wu J; Lou Z; Yuan J
    Oncogene; 2018 May; 37(18):2422-2431. PubMed ID: 29449692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.
    Dai Y; Liu S; Zhang WQ; Yang YL; Hang P; Wang H; Cheng L; Hsu PC; Wang YC; Xu Z; Jablons DM; You L
    Oncotarget; 2017 Jan; 8(3):4096-4109. PubMed ID: 27911857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.
    Rosenbluh J; Nijhawan D; Cox AG; Li X; Neal JT; Schafer EJ; Zack TI; Wang X; Tsherniak A; Schinzel AC; Shao DD; Schumacher SE; Weir BA; Vazquez F; Cowley GS; Root DE; Mesirov JP; Beroukhim R; Kuo CJ; Goessling W; Hahn WC
    Cell; 2012 Dec; 151(7):1457-73. PubMed ID: 23245941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
    Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
    Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Hippo Signaling Pathway Regulates Ovarian Function via the Proliferation of Ovarian Germline Stem Cells.
    Ye H; Li X; Zheng T; Hu C; Pan Z; Huang J; Li J; Li W; Zheng Y
    Cell Physiol Biochem; 2017; 41(3):1051-1062. PubMed ID: 28245464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
    Khanal P; Yeung B; Zhao Y; Yang X
    Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced nuclear localization of YAP1-2 contributes to EGF-induced EMT in NSCLC.
    Guo Q; Quan MY; Xu L; Cai Y; Cai JT; Li X; Feng G; Chen A; Yang W; Dhlamini Q; Jiang TF; Shen C; Chen C; Zhang JS
    J Cell Mol Med; 2022 Feb; 26(4):1013-1023. PubMed ID: 35014181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional coactivator YAP1 is overexpressed in osteoarthritis and promotes its progression by interacting with Beclin-1.
    Zhang Q; Fang X; Zhao W; Liang Q
    Gene; 2019 Mar; 689():210-219. PubMed ID: 30496783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.
    Archibald A; Al-Masri M; Liew-Spilger A; McCaffrey L
    Mol Biol Cell; 2015 Oct; 26(20):3578-95. PubMed ID: 26269582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage.
    Levy D; Adamovich Y; Reuven N; Shaul Y
    Mol Cell; 2008 Feb; 29(3):350-61. PubMed ID: 18280240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.